In prostate cancer, Leclerc et al. reported that elevated CD73 levels in the normal adjacent prostate epithelium are linked to a shorter period of biochemical recurrence-free survival, while elevated CD73 levels in the tumor stroma were associated with a prolonged duration of biochemical recurrence-free survival [83]. This evidence concerns the gene NT5E and prostate cancer.